Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/104850
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Implications of the LEGACY trial on US Atrial Fibrillation Patients: An NCDR Research to Practice (R2P) Project |
Author: | Gehi, A. O'Brien, E. Pathak, R. Sanders, P. Kennedy, K. Virani, S. Masoudi, F. Maddox, T. |
Citation: | American Journal of Cardiology, 2017; 119(4):579-584 |
Publisher: | Elsevier |
Issue Date: | 2017 |
ISSN: | 0002-9149 1879-1913 |
Statement of Responsibility: | Anil K. Gehi, Emily O'Brien, Rajeev K. Pathak, Prashanthan Sanders, Kevin F. Kennedy, Salim S. Virani, Frederick A. Masoudi and Thomas M. Maddox |
Abstract: | Abstract not available |
Keywords: | Humans Atrial Fibrillation Obesity Anti-Arrhythmia Agents Ambulatory Care Registries Multivariate Analysis Logistic Models Smoking Comorbidity Patient Selection Aged Aged, 80 and over Middle Aged Eligibility Determination United States Australia Female Male Weight Reduction Programs |
Rights: | © 2016 Elsevier Inc. All rights reserved. |
DOI: | 10.1016/j.amjcard.2016.10.044 |
Grant ID: | NHMRC |
Published version: | http://dx.doi.org/10.1016/j.amjcard.2016.10.044 |
Appears in Collections: | Aurora harvest 8 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.